Pancreatic and Bile Duct Stone Management - Global Strategic Business Report

The global market for Pancreatic and Bile Duct Stone Management was estimated at US$1.3 Billion in 2024 and is projected to reach US$1.6 Billion by 2030, growing at a CAGR of 3.3% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Pancreatic and Bile Duct Stone Management market.

Global Pancreatic and Bile Duct Stone Management Market - Key Trends & Drivers Summarized

What Is Driving the Growing Focus on Pancreatic and Bile Duct Stone Management?

Pancreatic and bile duct stone management has become a critical focus area in gastroenterology due to increasing prevalence of gallstone-related disorders, chronic pancreatitis, and bile duct obstructions. These conditions can lead to severe complications including infection, biliary colic, and obstructive jaundice if not effectively treated. Management typically involves minimally invasive endoscopic techniques to locate and extract stones, restore ductal patency, and alleviate symptoms.

Endoscopic retrograde cholangiopancreatography (ERCP) remains the cornerstone for diagnosis and intervention. This technique combines fluoroscopy and endoscopy to allow stone visualization, sphincterotomy, and retrieval using specialized accessories such as extraction balloons, baskets, and lithotripters. The increasing preference for less invasive, targeted therapies is boosting the demand for advanced tools designed to improve procedural efficiency and reduce patient recovery times.

How Are Techniques and Devices Evolving to Improve Clinical Outcomes?

Significant advancements have emerged in lithotripsy, stenting, and accessory device design. Intraductal lithotripsy methods, such as electrohydraulic lithotripsy (EHL) and laser lithotripsy, are increasingly used when stones are too large or impacted to be removed by conventional baskets. These technologies allow stone fragmentation under direct visualization, improving success rates in complex cases.

Single-use duodenoscopes and disposable ERCP tools are being adopted to reduce cross-contamination risks, especially in high-volume centers. Innovations in biliary and pancreatic stents are enhancing drainage post-extraction, supporting ductal healing, and reducing stricture-related complications. Fluoroscopy-free and radiation-reduced ERCP protocols are also being introduced, especially in pediatric and pregnant patient populations.

Where Is Demand for Stone Management Procedures Rising and Which Settings Lead Adoption?

Demand is growing across both developed and emerging markets. Rising incidence of gallstone-related complications, aging populations, and improvements in gastrointestinal disease detection are contributing to higher procedure volumes. Tertiary care hospitals, gastrointestinal specialty centers, and academic medical institutions are leading adopters of advanced stone management technologies.

In North America and Europe, reimbursement frameworks, training programs, and early adoption of new techniques are supporting market growth. Asia-Pacific is witnessing rapid expansion due to increasing access to diagnostic endoscopy, healthcare infrastructure development, and growing awareness of chronic biliary and pancreatic conditions. Outpatient endoscopy units are also expanding their capacity to perform ERCP-based stone retrieval procedures, driving demand for compact and mobile equipment setups.

Growth in the Pancreatic and Bile Duct Stone Management market is driven by several factors

Growth in the pancreatic and bile duct stone management market is driven by factors such as rising prevalence of gallstones and chronic pancreatitis, growing preference for minimally invasive endoscopic interventions, and continued advancements in lithotripsy and ductal access technologies. Increasing availability of disposable and single-use tools is improving procedural safety, particularly in infection-sensitive environments.

Expanding use of intraductal visualization systems, enhanced stone fragmentation techniques, and improved stent materials is enhancing procedural success rates and patient recovery. Growth in geriatric populations, who are more susceptible to bile duct complications, is further supporting demand. The emergence of day-care endoscopy units and increased procedural awareness among general physicians are also contributing to a broader treatment base and increased uptake of stone management solutions globally.

Scope Of Study:

The report analyzes the Pancreatic and Bile Duct Stone Management market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments: Product (ERCP Catheters, Guidewire, Sphincterotome, Dilation Balloon Catheters, Extraction Balloon Catheters, Extraction Basket Catheters, Biliary Stents, Self-Expandable Biliary Stents, Dilation Large-Balloon Catheters, Mechanical Lithotripsy, Electrohydraulic / Laser Lithotripsy); Indication (Pancreatic Stones Indication, Bile Duct Stones Indication); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use)

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the ERCP Catheters segment, which is expected to reach US$398.7 Million by 2030 with a CAGR of a 4.5%. The Mechanical Lithotripsy segment is also set to grow at 4.3% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $356.0 Million in 2024, and China, forecasted to grow at an impressive 6.3% CAGR to reach $317.4 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Pancreatic and Bile Duct Stone Management Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Pancreatic and Bile Duct Stone Management Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Pancreatic and Bile Duct Stone Management Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Allium Medical, Amecath, BD (Becton, Dickinson and Company), Boston Scientific Corporation, COOK Medical and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 44 companies featured in this Pancreatic and Bile Duct Stone Management market report include:

• Allium Medical
• Amecath
• BD (Becton, Dickinson and Company)
• Boston Scientific Corporation
• COOK Medical
• ConMed Corporation
• Dornier MedTech
• Duke Empirical
• Endo-Flex GmbH
• Fujifilm Holdings Corporation
• KARL STORZ SE & Co. KG
• Medi-Globe GmbH
• Medorah Meditek Pvt. Ltd.
• Medtronic plc
• Merit Medical Systems, Inc.
• Micro-Tech Endoscopy
• Olympus Corporation
• PENTAX Medical (HOYA Group)
• Taewoong Medical Co., Ltd.
• Zhejiang Chuangxiang Medical Tech

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

• Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
• Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
• Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
• Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
• Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
• Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
• Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.